SUNPHARMABSESun Pharmaceutical Industries LtdMediumNeutral
Announced Fri, 8 May · 19:50 IST

Completion and result of postal ballot dated 07 April 2026

Management Changes View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹1845.00
prior close
₹1827.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+1.1+1.2+1.1-0.0-1.2+1.0+1.8+3.2+1.9-3.1-2.5+4.2
Up moveDown movePending
AI summary

Sun Pharmaceutical Industries Limited has announced the completion of a postal ballot process that was initiated on 07 April 2026. The remote e-voting period ran from 09 April 2026 and concluded on 08 May 2026. Shareholders have duly approved the resolution by the requisite majority. As a result, Ms. Satyavavati Berera (DIN: 05002709) has been appointed as an Independent Director of the Company for a term of five years, effective 08 May 2026. The voting results and Scrutinizer's Report have been submitted to the stock exchanges and are available on the Company's website.

Likely market impact

The appointment of Ms. Satyavavati Berera as an Independent Director strengthens the Board's governance structure. As an Independent Director appointed through shareholder approval, this is a positive governance development for the company.